Skin Notation Profiles for Chlorodiphenyl (42% Chlorine) (CAS: 53469-21-9), Cyclohexanol (CAS: 108-93-0), Cyclohexanone (CAS: 108-94-1), Cyclonite (CAS: 121-82-4), and Diethylenetriamine (CAS: 111-40-0), 73481 [2020-25300]

Download as PDF Federal Register / Vol. 85, No. 223 / Wednesday, November 18, 2020 / Notices in concert, to retain the voting shares of Firstand Company, and thereby indirectly retain the voting shares of First State Bank, both of Hordville, Nebraska. Board of Governors of the Federal Reserve System, November 13, 2020. Michele Taylor Fennell, Deputy Associate Secretary of the Board. [FR Doc. 2020–25433 Filed 11–17–20; 8:45 am] BILLING CODE P President) 2200 North Pearl Street, Dallas, Texas 75201–2272: 1. Texas Heritage Bancshares, Inc., Hondo, Texas; to acquire voting shares of Medina Community Bancshares, Inc., and thereby indirectly acquire voting shares of Community National Bank, both of Hondo, Texas. Board of Governors of the Federal Reserve System, November 13, 2020. Michele Taylor Fennell, Deputy Associate Secretary of the Board. [FR Doc. 2020–25434 Filed 11–17–20; 8:45 am] FEDERAL RESERVE SYSTEM BILLING CODE P khammond on DSKJM1Z7X2PROD with NOTICES Formations of, Acquisitions by, and Mergers of Bank Holding Companies The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq.) (BHC Act), Regulation Y (12 CFR part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The public portions of the applications listed below, as well as other related filings required by the Board, if any, are available for immediate inspection at the Federal Reserve Bank(s) indicated below and at the offices of the Board of Governors. This information may also be obtained on an expedited basis, upon request, by contacting the appropriate Federal Reserve Bank and from the Board’s Freedom of Information Office at https://www.federalreserve.gov/foia/ request.htm. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). Comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors, Ann E. Misback, Secretary of the Board, 20th Street and Constitution Avenue NW, Washington, DC 20551–0001, not later than December 18, 2020. A. Federal Reserve Bank of Chicago (Colette A. Fried, Assistant Vice President) 230 South LaSalle Street, Chicago, Illinois 60690–1414: 1. First Mid Bancshares Inc., Mattoon, Illinois; to acquire voting shares of LINCO Bancshares, Inc., and thereby indirectly acquire voting shares of Providence Bank, both of Columbia, Missouri. B. Federal Reserve Bank of Dallas (Robert L. Triplett III, Senior Vice VerDate Sep<11>2014 17:59 Nov 17, 2020 Jkt 253001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [CDC–2019–0015, Docket Number NIOSH– 153–E] Skin Notation Profiles for Chlorodiphenyl (42% Chlorine) (CAS: 53469–21–9), Cyclohexanol (CAS: 108– 93–0), Cyclohexanone (CAS: 108–94– 1), Cyclonite (CAS: 121–82–4), and Diethylenetriamine (CAS: 111–40–0) National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of availability. AGENCY: NIOSH announces the availability of Skin Notation Profiles for Chlorodiphenyl (42% chlorine) (CAS: 53469–21–9), Cyclohexanol (CAS: 108– 93–0), Cyclohexanone (CAS: 108–94–1), Cyclonite (CAS: 121–82–4), and Diethylenetriamine (CAS: 111–40–0). DATES: The final documents were published on November 2, 2020 on the CDC website. ADDRESSES: The documents may be obtained at the following links: Chlorodiphenyl (42% chlorine) (CAS: 53469–21–9): https://www.cdc.gov/ niosh/docs/2021-100/; Cyclohexanol (CAS: 108–93–0): https://www.cdc.gov/niosh/docs/2021101/; Cyclohexanone (CAS: 108–94–1): https://www.cdc.gov/niosh/docs/2021103/; Cyclonite (CAS: 121–82–4): https:// www.cdc.gov/niosh/docs/2021-104/; Diethylenetriamine (CAS: 111–40–0): https://www.cdc.gov/niosh/docs/2021102/; FOR FURTHER INFORMATION CONTACT: Naomi Hudson (mail to: iuz8@cdc.gov), National Institute for Occupational SUMMARY: PO 00000 Frm 00027 Fmt 4703 Sfmt 9990 73481 Safety and Health, Centers for Disease Control and Prevention, 1090 Tusculum Ave., MS C–15, Cincinnati, OH 45226. Phone (513) 533–8388 (not a toll-free number). On March 15, 2019, NIOSH published a request for public review in the Federal Register [Federal Register Number 2019–04794] [84 FR 9524] on the draft versions of the documents skin notion profiles: SUPPLEMENTARY INFORMATION: Beta-Chloroprene (CAS: 126–99–8) Cyclohexanol (CAS: 108–93–0) Cyclohexanone (CAS: 108–94–1) Cyclonite (CAS: 121–82–4) Dioxane (CAS: 123–91–1) Diacetyl/2,3-Pentanedione (CAS: 431– 03–8; 600–14–6) Diethylenetriamine (CAS: 111–40–0) Chlorodiphenyl (42% chlorine) (CAS: 53469–21–9) Chlorodiphenyl (54% chlorine) (CAS: 11097–69–1) Toluene diisocyanates (CAS: 584–84–9; 91–08–7; 26471–62–5) Five of these documents have been finalized and published: Chlorodiphenyl (42% chlorine) (CAS: 53469–21–9), Cyclohexanol (CAS: 108– 93–0), Cyclohexanone (CAS: 108–94–1), Cyclonite (CAS: 121–82–4), and Diethylenetriamine (CAS: 111–40–0). All comments received were carefully reviewed and addressed, where appropriate. In response to comments received, revisions were made to clarify the data used by NIOSH in its support of the development of the skin notation assignments for these chemicals. NIOSH Skin Notation Profiles, Group E Responses to Peer Review and Public Comments can be found in the Supporting Documents section on www.regulations.gov for this docket. Comments for the draft documents on Beta-chloroprene (CAS: 126–99–8), Dioxane (CAS: 123–91–1), Diacetyl/2,3Pentanedione (CAS: 431–03–8/600–14– 6), Cholorodiphenyl (54% chlorine) (CAS: 110097–69–1) and Toluene diisocyanates (CAS: 584–84–9; 91–08–7; 26471–62–5) are still being considered by NIOSH. Authority: PHS Act, 42 U.S.C. 241(a)(1). John J. Howard, Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. [FR Doc. 2020–25300 Filed 11–17–20; 8:45 am] BILLING CODE 4163–18–P E:\FR\FM\18NON1.SGM 18NON1

Agencies

[Federal Register Volume 85, Number 223 (Wednesday, November 18, 2020)]
[Notices]
[Page 73481]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-25300]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[CDC-2019-0015, Docket Number NIOSH-153-E]


Skin Notation Profiles for Chlorodiphenyl (42% Chlorine) (CAS: 
53469-21-9), Cyclohexanol (CAS: 108-93-0), Cyclohexanone (CAS: 108-94-
1), Cyclonite (CAS: 121-82-4), and Diethylenetriamine (CAS: 111-40-0)

AGENCY: National Institute for Occupational Safety and Health (NIOSH) 
of the Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of availability.

-----------------------------------------------------------------------

SUMMARY: NIOSH announces the availability of Skin Notation Profiles for 
Chlorodiphenyl (42% chlorine) (CAS: 53469-21-9), Cyclohexanol (CAS: 
108-93-0), Cyclohexanone (CAS: 108-94-1), Cyclonite (CAS: 121-82-4), 
and Diethylenetriamine (CAS: 111-40-0).

DATES: The final documents were published on November 2, 2020 on the 
CDC website.

ADDRESSES: The documents may be obtained at the following links:
    Chlorodiphenyl (42% chlorine) (CAS: 53469-21-9): https://www.cdc.gov/niosh/docs/2021-100/;
    Cyclohexanol (CAS: 108-93-0): https://www.cdc.gov/niosh/docs/2021-101/;
    Cyclohexanone (CAS: 108-94-1): https://www.cdc.gov/niosh/docs/2021-103/;
    Cyclonite (CAS: 121-82-4): https://www.cdc.gov/niosh/docs/2021-104/
;
    Diethylenetriamine (CAS: 111-40-0): https://www.cdc.gov/niosh/docs/2021-102/;

FOR FURTHER INFORMATION CONTACT: Naomi Hudson (mail to: [email protected]), 
National Institute for Occupational Safety and Health, Centers for 
Disease Control and Prevention, 1090 Tusculum Ave., MS C-15, 
Cincinnati, OH 45226. Phone (513) 533-8388 (not a toll-free number).

SUPPLEMENTARY INFORMATION: On March 15, 2019, NIOSH published a request 
for public review in the Federal Register [Federal Register Number 
2019-04794] [84 FR 9524] on the draft versions of the documents skin 
notion profiles:

Beta-Chloroprene (CAS: 126-99-8)
Cyclohexanol (CAS: 108-93-0)
Cyclohexanone (CAS: 108-94-1)
Cyclonite (CAS: 121-82-4)
Dioxane (CAS: 123-91-1)
Diacetyl/2,3-Pentanedione (CAS: 431-03-8; 600-14-6)
Diethylenetriamine (CAS: 111-40-0)
Chlorodiphenyl (42% chlorine) (CAS: 53469-21-9)
Chlorodiphenyl (54% chlorine) (CAS: 11097-69-1)
Toluene diisocyanates (CAS: 584-84-9; 91-08-7; 26471-62-5)

    Five of these documents have been finalized and published: 
Chlorodiphenyl (42% chlorine) (CAS: 53469-21-9), Cyclohexanol (CAS: 
108-93-0), Cyclohexanone (CAS: 108-94-1), Cyclonite (CAS: 121-82-4), 
and Diethylenetriamine (CAS: 111-40-0). All comments received were 
carefully reviewed and addressed, where appropriate. In response to 
comments received, revisions were made to clarify the data used by 
NIOSH in its support of the development of the skin notation 
assignments for these chemicals. NIOSH Skin Notation Profiles, Group E 
Responses to Peer Review and Public Comments can be found in the 
Supporting Documents section on www.regulations.gov for this docket. 
Comments for the draft documents on Beta-chloroprene (CAS: 126-99-8), 
Dioxane (CAS: 123-91-1), Diacetyl/2,3-Pentanedione (CAS: 431-03-8/600-
14-6), Cholorodiphenyl (54% chlorine) (CAS: 110097-69-1) and Toluene 
diisocyanates (CAS: 584-84-9; 91-08-7; 26471-62-5) are still being 
considered by NIOSH.

    Authority: PHS Act, 42 U.S.C. 241(a)(1).

John J. Howard,
Director, National Institute for Occupational Safety and Health, 
Centers for Disease Control and Prevention.
[FR Doc. 2020-25300 Filed 11-17-20; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.